Cardiac Arrhythmia Monitoring Devices Market to Grow by a Substantial CAGR of 6.33% by 2027, As per DelveInsight
05 Jul 2022
BiosimilarCell Therapy
Increase in demand for Cardiac Arrhythmia Monitoring Devices is primarily attributed to the rising prevalence of cardiovascular diseases, rising expenditure on cardiac health globally, rising adoption of mobile and telemetry cardiac monitors, rising prevalence of cardiac arrhythmias, rising technological advancements in monitoring devices, among others are also expected to bolster the demand for these services during the forecast period (2022-2027).
LAS VEGAS, July 5, 2022 /PRNewswire/ -- DelveInsight's
Cardiac Arrhythmia Monitoring Devices Market Insights and Forecast report provides the current and forecast Cardiac Arrhythmia Monitoring Devices Market, upcoming innovations in the devices, individual market shares, challenges, drivers and barriers, market trends, and key competitors in the Cardiac Arrhythmia Monitoring Devices Market.
Some of the salient features from the
Cardiac Arrhythmia Monitoring Devices Market report:
As per DelveInsight analysis, in terms of revenue share, North America is predicted to register the fastest growth in the Cardiac Arrhythmia Monitoring Devices market.
Some of the Global Cardiac Arrhythmia Monitoring Device companies with their surgery procedures/ products in various stages of development include
Abbott Laboratories, Boston Scientific Corporation, Avanos Medical, Inc., Auris Health, Inc., Olympus, CONMED Corporation, ERBE ELEKTROMEDIZIN GMBH, AngioDynamics, Medtronic Inc., AtriCure, Inc., Biosense Webster, Inc., Teleflex Incorporated, St. Jude Medical Inc., Lepu Medical Technology (Beijing) Co., Ltd., MicroPort Scientific Corporation, and others.
DelveInsight analyzes that the global cardiac arrhythmia monitoring devices market will grow at a CAGR of 6.33% during the forecast period from 2022 to 2027.
On
January 10, 2022, Global Instrumentation LLC received the CE Mark certification for the M5 wearable ECG recorder that had earlier been approved by the Food and Drug Administration authority in January 2021.
On
May 02, 2022, Agatsa, the world's smallest
ECG Maker received Food and Drug Administration clearance along with its entry into the United States market.
in
July 2021, Abbott introduced
Jot Dx™ Insertable Cardiac Monitor for continuous remote monitoring, leading to a faster time to diagnosis compared to ICMs that may use traditional bedside monitors.
On
March 12, 2021, Qardio had received the United States Food and Drug Administration clearance for the
QardioCore continuous ambulatory ECG.
On
February 10, 2021, CardiacSense Medical Grade Watch received CE Mark approval for continuous detection of atrial fibrillation.
To pick on the latest highlights related to Cardiac Arrhythmia Monitoring Devices market, get the snapshot of the key highlights entailed in the
Cardiac Arrhythmia Monitoring Devices Market Report
Cardiac Arrhythmia Monitoring Devices Overview
A heart arrhythmia is an irregular heartbeat and tends to occur when the electrical signals that coordinate the heart beats do not work appropriately. The faulty signals in the heart cause it to beat too fast (tachycardia), too slow (bradycardia), or irregularly. The cardiac arrhythmia monitoring devices are small and wearable devices that track the rhythm of the heart. They are used for the detection or determination of irregular heartbeats (also known as cardiac arrhythmia). While most arrhythmias are harmless, some can be serious or even life-threatening.
Cardiac Arrhythmia Monitoring Devices Market Insight
Geographically, the Global Cardiac Arrhythmia Monitoring Devices market is studied for North America, Europe, Asia-Pacific, and the Rest of the World. In terms of revenue share North America currently leads the Global Cardiac Arrhythmia Monitoring Devices market and is expected to remain constant during the forecast period. This domination is owing to the rising prevalence of arrhythmias, growing technological advancements in the cardiac monitoring devices, rising number of awareness programs, and the rising geriatric population is also likely to increase the regional cardiac arrhythmia monitoring devices market.
Further, various strategic development and launch of new products will also drive the market. For instance, in
July 2021, Abbott introduced
Jot Dx™ Insertable Cardiac Monitor for continuous remote monitoring, leading to a faster time to diagnosis compared to ICMs that may use traditional bedside monitors. Furthermore, on
November 04, 2019, Shimmer received the CE Mark approval for its ECGmd Holter monitor electrocardiograph as a Class IIa medical device under the Medical Device Directive ((93/42/EEC).
Click here to understand more about the key players in the Cardiac Arrhythmia Monitoring Devices Market and their future @
Cardiac Arrhythmia Monitoring Devices Future Assessment
Cardiac Arrhythmia Monitoring Devices Market Dynamics
The cardiac arrhythmia monitoring devices market is witnessing a growth in product demand owing to various reasons, one of the major factors influencing the growth of the cardiac arrhythmia monitoring devices market is the
rising prevalence of cardiovascular disorders worldwide. Other factors that are also responsible for a major boost in the cardiac arrhythmia monitoring devices market include
technological advancements associated with the cardiac arrhythmia devices and the r
ising number of awareness programs in the coming years. Also, owing to the rising prevalence of cardiac arrhythmias leading to
huge investments by cardiac arrhythmia monitoring device
manufacturers, there will be a
higher demand for cardiac arrhythmia monitoring devices as they are intended for the
management of atrial fibrillation and
assessment of cryptogenic stroke, thereby influencing the overall cardiac arrhythmia monitoring devices market positively.
Conversely, however limitations such as
complications that are associated with the cardiac arrhythmia monitoring devices and the
high cost of treatment involving cardiac arrhythmia monitoring devices are some of the factors expected to limit the Cardiac Arrhythmia Monitoring Devices market.
Furthermore, the
ongoing COVID-19 pandemic has highly impacted the market for Cardiac Arrhythmia Monitoring Devices as
people are not able to visit the hospital for elective surgery, they have preferred devices that can help in real-time monitoring from the home. There had been a temporary negative impact on the cardiac arrhythmia monitoring devices market owing to the
shutting down of the manufacturing units, and
disruption caused in the supply chain among other factors. But after the resumption of hospital visits and the opening of the manufacturing facilities, the market for cardiac arrhythmia monitoring had resumed its growth and can be anticipated to spur in the forecast period of 2022-27.
To gain a better understanding of the COVID-19 impact on Cardiac Arrhythmia Monitoring Devices, get a snapshot of the
COVID-19 Impact On Cardiac Arrhythmia Monitoring Devices Market
Scope of the
Cardiac Arrhythmia Monitoring Devices Market Report
Coverage
: Global
Study Period: 2019-2027
Market Segmentation By Device Type - ECG Monitors, Implantable Cardiac Monitors, Holter Monitors, Mobile Cardiac Telemetry And Others
Market Segmentation By Application - Tachycardia, Bradycardia, Atrial Fibrillation, And Others
Market Segmentation By End-User- Hospitals And Clinics, Ambulatory Centres, Diagnostic Centres And Others
Market Segmentation By Geography - North America, Europe, Asia-Pacific, and Rest of World
Key Cardiac Arrhythmia Monitoring Devices Companies - Abbott Laboratories, Boston Scientific Corporation, Avanos Medical, Inc., Auris Health, Inc., Olympus, CONMED Corporation, ERBE ELEKTROMEDIZIN GMBH, AngioDynamics, Medtronic Inc., AtriCure, Inc., Biosense Webster, Inc., Teleflex Incorporated, St. Jude Medical Inc., Lepu Medical Technology (Beijing) Co., Ltd., MicroPort Scientific Corporation, and others.
Porter's Five Forces Analysis
Product Profiles
Case Studies
KOL's Views
Analyst's View
Delveinsight Analysis: The global cardiac arrhythmia monitoring devices market will grow at a CAGR of 6.33% during the forecast period from 2022 to 2027.
Know more about which MedTech player is set to emerge as the trendsetter in the Global Cardiac Arrhythmia Monitoring Devices Market @
Key Cardiac Arrhythmia Monitoring Devices Companies Analysis
Table of Contents
Learn more about the report offerings
@
Cardiac Arrhythmia Monitoring Devices Market Outlook
Related Reports
Implantable Cardiac monitors Market
"DelveInsight's
'Implantable Cardiac monitors (ICM) - Market Insight, Competitive Landscape and Market Forecast, 2027' report delivers an in-depth understanding of Implantable Cardiac monitors (ICM) and the historical and forecasted Implantable Cardiac monitors (ICM) market trends, market drivers & barriers, unmet needs, and key companies involved such as
Cardiac Restoration Systems Market
"DelveInsight's
'Cardiac Restoration Systems - Market Insight, Competitive Landscape and Market Forecast, 2027' report delivers an in-depth understanding of Cardiac Restoration Systems and the historical and forecasted Cardiac Restoration Systems market trends, market drivers & barriers, unmet needs, and key companies involved such as
Abbott, BioVentrix, CryoLife, Inc, Edwards Lifesciences Corporation, NeoChord, Inc., XELTIS, and others.
Cardiac Ablation Devices
Global
Cardiac Ablation Devices Market report delivers an in-depth understanding of Cardiac Ablation Devices and the historical and forecasted Cardiac Ablation Devices market trends, market drivers & barriers, unmet needs, and key companies involved such as
Cardiac Valvulotome Market
"DelveInsight's
'Cardiac Valvulotome - Market Insight, Competitive Landscape and Market Forecast, 2027' report delivers an in-depth understanding of Cardiac Valvulotome and the historical and forecasted Cardiac Valvulotome market trends, globally, which comprises of North America, Europe, APAC, and RoW, market drivers & barriers, unmet needs, and key companies involved such as
Braun Melsungen AG, LeMaitre Vascular, Inc., Andramed GmbH,BD., InvaMed, Koven Technology Canada Inc, and others.
Cardiac Resynchronization Therapy Market
"DelveInsight's
'Cardiac Resynchronization Therapy - Market Insight, Competitive Landscape and Market Forecast, 2027' report delivers an in-depth understanding of Cardiac Resynchronization Therapy and the historical and forecasted Cardiac Resynchronization Therapy market trends, globally, which comprises of North America, Europe, APAC, and RoW, market drivers & barriers, unmet needs, and key companies involved such as
Boston Scientific Corporation, Medtronic, Medico S.p. A, Microport Scientific Corporation, Biotronik, EBR Systems, Abbott, and others.
Cardiac Restoration Systems Market
DelveInsight's
'Cardiac Restoration Systems - Market Insight, Competitive Landscape and Market Forecast, 2027' report delivers an in-depth understanding of Cardiac Restoration Systems and the historical and forecasted Cardiac Restoration Systems market trends, globally, which comprises of North America, Europe, APAC, and RoW, market drivers & barriers, unmet needs, and key companies involved such as
Abbott, BioVentrix,CryoLife, Edwards Lifesciences Corporation,NeoChord, XELTIS, and others.
Cardiac Output Monitors Market
"DelveInsight's
'Cardiac Output Monitors - Market Insight, Competitive Landscape and Market Forecast, 2027' report delivers an in-depth understanding of Cardiac Output Monitors and the historical and forecasted Cardiac Output Monitors market trends, globally, which comprises of North America, Europe, APAC, and RoW, market drivers & barriers, unmet needs, and key companies involved such as
Osypka Medical GmbH, CNSystems Medizintechnik GmbH., Uscom, Deltex Medical Limited, Edward Lifesciences Corporation, ICU Medical, Inc., LiDCO, Baxter., Getinge AB., GE Healthcare (GENERAL ELECTRIC COMPANY), Biotronik, and others.
Cardiac Monitoring Devices Market
Global Cardiac Monitoring Devices Market report delivers an in-depth understanding of Cardiac Monitoring Devices and the historical and forecasted Cardiac Monitoring Devices market trends, market drivers & barriers, unmet needs, and key companies involved such as
Cardiac Assist Devices Market
Global Cardiac Assist Devices Market report delivers an in-depth understanding of Global Cardiac Assist Devices and the historical and forecasted Global Cardiac Assist Devices market trends, market drivers & barriers, unmet needs, and key companies involved such as
Abbott Laboratories, Teleflex Incorporated, SynCardia Systems, LLC, St. Jude Medical Inc, CARMAT, CorWave SA, Medtronic PLC, Terumo Heart, NovaPump GmbH, Getinge AB Balton Ltd, Meril Life Sciences Pvt. Ltd, Thoratec Corporation, and others.
3D Cardiac Mapping System Market
"DelveInsight's
'3D Cardiac Mapping System - Market Insight, Competitive Landscape and Market Forecast, 2027' report delivers an in-depth understanding of 3D Cardiac Mapping System and the historical and forecasted 3D Cardiac Mapping System market trends, globally, which comprises of North America, Europe, APAC, and RoW, market drivers & barriers, unmet needs, and key companies involved such as
Biosense Webster, (Jhonson & Jhonson), Boston Scientific Corporation, Abbott, Kardium, Medtronic, Catheter Robotics, Inc, Lepu Medical, EP Solutions SA, and others.
Browse Through Our Blog Posts
With advancements in Innovative Technology,
Cardiac Monitoring Devices Market
is Booming Significantly
Mapping the Increasing Burden of Heart FailureHeart Failure
: What Does it Bring for Healthcare Market Companies?
What Factors are Shaping the Trends in the
Implantable Cardiac Monitors Market
?
Cost-effectiveness, Advanced Technology, Rising Demand Pushes the
Cardiac Assist Devices Market
Other Trending Reports by DelveInsight
Diagnostic Imaging Equipment Market
|
|
Sialidosis Market
|
Filgrastim Biosimilar Insight
|
Pain Management Devices Market
|
Primordial Dwarfism Market
|
Non-cystic Fibrosis Bronchiectasis Market
|
Microsatellite Stable Colorectal Cancer Market
|
Cystinuria Market
|
Deep Vein Thrombosis Market
|
Acquired Immunodeficiency Syndrome Market
|
Gene and Cell Therapies in Rare Disorder Market
|
Pediatric Growth Hormone Deficiency (PGHD) Market
|
Pain Management Devices Market
|
Diagnostic Imaging Equipment Market
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Connect With Us at LinkedIn
| Facebook | Twitter
Contact Us
[email protected]
+1(919)321-6187
www.delveinsight.com
Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
Targets
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.